# Uranium Royalty Corp.: overview

UROY · Nasdaq · CIK 2143673 · [Financials](/sectors/financials.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/uroy.md) · [Financials](/companies/uroy/financials.md) · [Filings](/companies/uroy/filings.md) · [Insiders](/companies/uroy/insiders.md)

Latest reported revenue: [$51.0m](/filings/0001193125-26-390681.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001193125-26-390681).

## Last eight quarters

| Line item | Unit | period not labelled (2025-07-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: |
| Revenue | $m | [24.2](/filings/0001193125-26-390681.md) | [51.0](/filings/0001193125-26-390681.md) |
| Gross margin | % | not reported | not reported |
| Operating margin | % | [9.3%](/filings/0001193125-26-390681.md) | [32.2%](/filings/0001193125-26-390681.md) |
| Net margin | % | [4.2%](/filings/0001193125-26-390681.md) | [31.9%](/filings/0001193125-26-390681.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001193125-26-390681.md) | [0.10](/filings/0001193125-26-390681.md) |
| Free cash flow | $m | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

## Last five fiscal years

| Line item | Unit | FY (2024-04-30) | FY (2025-04-30) | FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [31.2](/filings/0001193125-26-321135.md) | [11.2](/filings/0001193125-26-321135.md) | [187](/filings/0001193125-26-321135.md) |
| Gross margin | % | not reported | not reported | not reported |
| Operating margin | % | [16.3%](/filings/0001193125-26-321135.md) | [(30.7%)](/filings/0001193125-26-321135.md) | [25.9%](/filings/0001193125-26-321135.md) |
| Net margin | % | [43.9%](/filings/0001193125-26-321135.md) | [(40.2%)](/filings/0001193125-26-321135.md) | [21.5%](/filings/0001193125-26-321135.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001193125-26-321135.md) | [(0.04)](/filings/0001193125-26-321135.md) | [0.29](/filings/0001193125-26-321135.md) |
| Free cash flow | $m | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uroy/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Simcoe Capital LLC](/funds/2109203.md) | 2026-06-30 | $3.3m | 1,197,988 |  | New +1,197,988 |
| [Financial Security Advisor, Inc.](/funds/1997602.md) | 2026-06-30 | $36.3k | 13,052 |  | New +13,052 |
| [HARBOUR INVESTMENTS, INC.](/funds/810121.md) | 2026-06-30 | $1.8k | 630 |  | New +630 |
| [Heritage Wealth Advisors](/funds/1591122.md) | 2026-06-30 | $556 | 200 |  | New +200 |

## Recent filings

[All 23 filings](/companies/uroy/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 21:20 ET | [S-1](/filings/0001493152-26-045386.md) | Registration statement | 0001493152-26-045386 |
| 2026-09-15 | 20:05 ET | [8-K](/filings/0001493152-26-042740.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-042740 |
| 2026-09-14 | 20:36 ET | [10-Q](/filings/0001193125-26-390681.md) | Quarterly report, period 2026-07-31 | 0001193125-26-390681 |
| 2026-08-28 | 20:05 ET | [10-K/A](/filings/0001493152-26-040580.md) | Annual report, amended, period 2026-04-30 | 0001493152-26-040580 |
| 2026-08-07 | 21:24 ET | [8-K](/filings/0001493152-26-036666.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036666 |
| 2026-07-28 | 20:41 ET | [10-K](/filings/0001193125-26-321135.md) | Annual report, period 2026-04-30 | 0001193125-26-321135 |

## Latest annual report

[Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0001193125-26-321135.md), filed Jul 28, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2143673
- Tickers: UROY
- Exchange: Nasdaq
- SIC code: 6221 Commodity Contracts Brokers & Dealers
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.
